KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Exchange Rate Effect (2016 - 2025)

Xenon Pharmaceuticals (XENE) has disclosed Exchange Rate Effect for 13 consecutive years, with -$104000.0 as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 91.01% to -$104000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $458000.0 through Dec 2025, up 127.39% year-over-year, with the annual reading at $458000.0 for FY2025, 127.39% up from the prior year.
  • Exchange Rate Effect for Q4 2025 was -$104000.0 at Xenon Pharmaceuticals, down from -$6000.0 in the prior quarter.
  • The five-year high for Exchange Rate Effect was $814000.0 in Q4 2022, with the low at -$2.7 million in Q3 2022.
  • Average Exchange Rate Effect over 5 years is -$195700.0, with a median of -$35000.0 recorded in 2025.
  • The sharpest move saw Exchange Rate Effect skyrocketed 1079.71% in 2022, then tumbled 722.03% in 2024.
  • Over 5 years, Exchange Rate Effect stood at $69000.0 in 2021, then surged by 1079.71% to $814000.0 in 2022, then plummeted by 69.78% to $246000.0 in 2023, then plummeted by 570.33% to -$1.2 million in 2024, then skyrocketed by 91.01% to -$104000.0 in 2025.
  • According to Business Quant data, Exchange Rate Effect over the past three periods came in at -$104000.0, -$6000.0, and $632000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.